Related references
Note: Only part of the references are listed.Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma
Elizabeth D. Thompson et al.
GUT (2017)
CAR-T Cell Therapy for Lymphoma
Carlos A. Ramos et al.
ANNUAL REVIEW OF MEDICINE, VOL 67 (2016)
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
Xiuli Wang et al.
BLOOD (2016)
Encouraging results for PD-1 inhibition in gastric cancer
Elizabeth C. Smyth et al.
LANCET ONCOLOGY (2016)
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
Kei Muro et al.
LANCET ONCOLOGY (2016)
Landscape of tumor-infiltrating T cell repertoire of human cancers
Bo Li et al.
NATURE GENETICS (2016)
Novel targets in the treatment of advanced gastric cancer: a perspective review
Elisa Fontana et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2016)
Clinicopathological and prognostic significance of FOXP3+tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis
Daqing Jiang et al.
BMC CANCER (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial
Ming Zeng et al.
LANCET (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Pembrolizumab versus Ipilimumab in Advanced Melanoma
Caroline Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Signatures of tumour immunity distinguish Asian and non-Asian gastric adenocarcinomas
Suling J. Lin et al.
GUT (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis
M. Constanza Camargo et al.
GUT (2014)
Prognostic implications of tumor-infiltrating FoxP3+regulatory T cells and CD8+cytotoxic T cells in microsatellite-unstable gastric cancers
Kyung-Ju Kim et al.
HUMAN PATHOLOGY (2014)
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Charles S. Fuchs et al.
LANCET (2014)
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial
Hugo E. R. Ford et al.
LANCET ONCOLOGY (2014)
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
Hansjochen Wilke et al.
LANCET ONCOLOGY (2014)
Comprehensive molecular characterization of gastric adenocarcinoma
Adam J. Bass et al.
NATURE (2014)
PD-1 blockade induces responses by inhibiting adaptive immune resistance
Paul C. Tumeh et al.
NATURE (2014)
Cancer Immunotherapy Based on Mutation-Specific CD4+T Cells in a Patient with Epithelial Cancer
Eric Tran et al.
SCIENCE (2014)
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Marco L. Davila et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patients
Shinichi Kageyama et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Microsatellite Instability Status in Gastric Cancer: A Reappraisal of Its Clinical Significance and Relationship with Mucin Phenotypes
Joo-Yeun Kim et al.
KOREAN JOURNAL OF PATHOLOGY (2013)
Primer on tumor immunology and cancer immunotherapy
Timothy J. Harris et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Heteroclitic serological response in esophageal and prostate cancer patients after NY-ESO-1 protein vaccination
Junji Kawada et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection
Ji Yeong An et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer
Toru Masuzawa et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2012)
Salvage Chemotherapy for Pretreated Gastric Cancer: A Randomized Phase III Trial Comparing Chemotherapy Plus Best Supportive Care With Best Supportive Care Alone
Jung Hun Kang et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Functional differences between low- and high-affinity CD8+ T cells in the tumor environment
Rinke Bos et al.
ONCOIMMUNOLOGY (2012)
Heterogeneous amplification of ERBB2 in primary lesions is responsible for the discordant ERBB2 status of primary and metastatic lesions in gastric carcinoma
Min A. Kim et al.
HISTOPATHOLOGY (2011)
High microsatellite instability predicts good prognosis in intestinal-type gastric cancers
Hyunki Kim et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Machine learning competition in immunology - Prediction of HLA class I binding peptides
Guang Lan Zhang et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
Clinical Impact of Tumor-Infiltrating Lymphocytes for Survival in Stage II Colon Cancer
Won-Suk Lee et al.
CANCER (2010)
Inflammatory Processes Triggered by Helicobacter pylori Infection Cause Aberrant DNA Methylation in Gastric Epithelial Cells
Tohru Niwa et al.
CANCER RESEARCH (2010)
Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
Christy Ralph et al.
CLINICAL CANCER RESEARCH (2010)
Gastric Cancer: A Primer on the Epidemiology and Biology of the Disease and an Overview of the Medical Management of Advanced Disease
Manish A. Shah et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Helicobacter pylori: gastric cancer and beyond
D. Brent Polk et al.
NATURE REVIEWS CANCER (2010)
Chemosensitivity and Survival in Gastric Cancer Patients with Microsatellite Instability
Eiji Oki et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies
Karl S. Peggs et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Immune profile and mitotic index of metastatic melanoma lesions enhance clinical staging in predicting patient survival
Dusan Bogunovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432
Masatoshi Aoki et al.
VACCINE (2009)
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
H. E. Lee et al.
BRITISH JOURNAL OF CANCER (2008)
Helicobacter pylori infection and development of pancreatic cancer
Catherine de Martel et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival
Mario Falchetti et al.
HUMAN PATHOLOGY (2008)
Analysis of peripheral and local anti-tumor immune response in esophageal cancer patients after NY-ESO-1 protein vaccination
Hisashi Wada et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Localisation pattern of Foxp3+ regulatory T cells is associated with clinical behaviour in gastric cancer
Y. Mizukami et al.
BRITISH JOURNAL OF CANCER (2008)
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 study group
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
An open-label, multinational, multicenter study of G17DT vaccination combined with cisplatin and 5-fluorouracil in patients with untreated, advanced gastric or gastroesophageal cancer: The GC4 study
JA Ajani et al.
CANCER (2006)
Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers
S Beghelli et al.
SURGERY (2006)
Gastric cancer: global pattern of the disease and an overview of environmental risk factors
D. Forman et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2006)
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
V Lennerz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The impact of self-tolerance on the polyclonal CD8+ T cell repertoire
HWHG Kessels et al.
JOURNAL OF IMMUNOLOGY (2004)
Lymphocyte-rich gastric cancer: Associations with Epstein-Barr virus, microsatellite instability, histology, and survival
KL Grogg et al.
MODERN PATHOLOGY (2003)
Distinct clinical features and outcomes of gastric cancers with microsatellite instability
HS Lee et al.
MODERN PATHOLOGY (2002)
Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas
K Mashino et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
